Impact of anti-CD20 monoclonal antibodies on serologic response to

Monoclonal Antibodies: A Tool in Clinical Research - Waliza Ansar, Shyamasree Ghosh, 2013

Frontiers IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies

Overview of therapeutic monoclonal antibodies - UpToDate

The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy

British Journal of Haematology

Role of Pharmacist Intervention in the Safe Administration of Anti-CD20 Monoclonal Antibodies

A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia

Humoral and cellular responses after a third dose of BNT162b2 vaccine in patients treated for lymphoid malignancies

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

British Journal of Haematology

Frontiers Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents

Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis